• SIGN IN
  • GET HELP
  •  

    Home Study Details


    Program Type

    Home Study Webcast

    Credits

    1.25 Contact Hour(s)

    Release Date

    Wednesday, February 28, 2018

    Offline Date

    Sunday, August 30, 2020

    ACPE Expiration Date

    Sunday, August 30, 2020

    Target Audience

    Pharmacist, Nurse

    Cost

    $4.00

    • Overview

      The release of the PARADIGM-HF study and approval of sacubitril/valsartan provided a new treatment option (ARNIs) that could lead to better outcomes for patients with heart failure. This activity will provide an overview of the currently recommended morbidity and mortality-reducing agents for patients with heart failure. It will summarize key clinical trials that have led to the current recommendations for medication use in heart failure, with specific emphasis on the evidence around the use of ARNIs, and the role these could play in future heart failure management.

      Rating

         4.75  out of 5

      Handouts

      • Slide Document :   17162H01_4pp.pdf
      • Slide Document :   17162H01_2pp.pdf

      Financial Support By

      PharmCon
    • Pharmacist

      Summarize key evidence that supports current standards of care for patients with heart failure
      List the medications currently considered standard of care for patients with heart failure
      Describe the mechanism and role of angiotensin receptor/neprilysin inhibitors (ARNIs) in heart failure

      Nurse

      Describe the mechanism and role of angiotensin receptor/neprilysin inhibitors (ARNIs) in heart failure
      Summarize key evidence that supports current standards of care for patients with heart failure
      List the medications currently considered standard of care for patients with heart failure
    • Activity Type

      Knowledge

      CE Broker

      20-580451

      Universal Activity Number

      Pharmacist 0798-0000-17-162-H01-P
      Nurse 0798-0000-17-162-H01-P

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.


    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).